Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Derivative financial instruments

v2.4.0.6
Note 11 - Derivative financial instruments
3 Months Ended
Apr. 01, 2012
Derivative Instruments and Hedging Activities Disclosure [Text Block]
11.      Derivative financial instruments

The Company has entered into forward foreign exchange contracts to reduce its exposure to foreign exchange currency rate fluctuations related to forecasted Canadian dollar denominated payroll, rent and utility cash flows in the first four months of fiscal 2012, and Mexican peso denominated payroll, rent and utility cash flows in the twelve months of 2012. These contracts were effective as hedges from an economic perspective, but did not meet the requirements for hedge accounting under ASC 815 “Derivatives and Hedging”. Accordingly, changes in the fair value of these contracts were recognized into net income in the consolidated statement of operations and comprehensive income. The Company does not enter into forward foreign exchange contracts for trading or speculative purposes.

The following table presents a summary of the outstanding foreign currency forward contracts as at April 1, 2012:

Currency
Buy/Sell
Foreign Currency Amount
 
Notional Contract Value in USD
 
Canadian Dollar
Buy
 CAD 1,800
  $ 1,714  
Mexican Peso
Buy
 MXN 146,783
  $ 11,150  

The unrealized gain recognized in earnings as a result of revaluing the instruments to fair value on April 1, 2012 was $462 which was included in cost of sales in the statement of operations and comprehensive income. Fair value was determined using the market approach with valuation based on market observables (Level 2 quantitative inputs in the hierarchy set forth under ASC 820). The realized gain on these contracts was $387, and is included as a component of cost of sales, in the consolidated statement of operations and comprehensive income.  The Company did not enter into any derivative financial instruments contracts during the first quarter of 2011.

The following table presents the fair value of the Company’s derivative instruments located on the consolidated balance sheet as at the following dates:

   
April 1, 2012
   
January 1, 2012
 
Prepaid Expenses
  $ 420     $ 190  
Accrued Liabilities
          (233 )
Net unrealized gain on derivative financial instruments                                                                                                       
  $ 420     $ (43